Capital Inc. Bdc serves as Executive at TRANZYME INC, where they oversee executive responsibilities. Since joining the company, Capital Inc. Bdc has executed 5 insider transactions totaling $7.0M, demonstrating a bullish approach to their equity position. Their most recent transaction on May 8, 2019 involved purchasing 200,000 shares valued at $3.0M.
Capital Inc. Bdc currently holds 2,388,088 shares of TRANZYME INC (TZYM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Capital Inc. Bdc has been a net buyer of TZYM stock. They have purchased $7.0M and sold $0 worth of shares.
Capital Inc. Bdc's most recent insider trade was on May 8, 2019, when they purchased 200,000 shares at $15.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Apr 6, 2011 | TZYM | $0 | Conversion | 915,430 | $N/A | Discretionary |
| Apr 6, 2011 | TZYM | $4.0M | Purchase | 1,000,000 | $4.00 | Discretionary |
| Apr 6, 2011 | TZYM | $0 | Conversion | 307,287 | $N/A | Discretionary |